Drug Trial Radar · NCT01278173
A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)
Last checked: Nov 19, 2026Latest source record: Jun 7, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
65
Actual
Start
Dec 2010
Primary completion
May 2015
Study completion May 2015
Sponsor
- Lead sponsor
- Lundbeck LLCIndustry
- Sponsor type
- Industry
- First posted
- Jan 17, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Supportive care
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the change in visual fields by means of automated static perimetry and to evaluate the change in retinal structure by means of spectral domain optical coherence tomography (SD-OCT) in adult patients with refractory complex partial seizures (CPS) being treated with vigabatrin (Sabril®)
Conditions
- Adult Refractory Complex Partial Seizures
Interventions
SabrilDrug
Sabril: 500 mg tablets, orally. Physicians will dose their patients according to guidance provided in the product label.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Reference Value in Field Width as Measured by 30-2 SITA Fast in Field Sensitivity (Mean Deviation - MD in dB)Time frame: Baseline (Month 0), Month 3, Month 6, Month 9, Month 12
- Change From Reference Value in Average RNFL (Retinal Nerve Fiber Layer) Thickness (µm) as Measured by SD-OCT (Spectral Domain-Optical Coherence Tomography)Time frame: Baseline (Month 0), Month 3, Month 6, Month 9, Month 12
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
California Pacific Medical Center
San Francisco, California
Yale Medical Center
New Haven, Connecticut
CNMRI
Dover, Delaware
Sunrise Clinical Research Group
Hollywood, Florida
University of South Florida
Tampa, Florida
Peachtree Neurological Clinic
Atlanta, Georgia
Idaho Comprehensive Epilepsy Center
Boise, Idaho
OSF Saint Francis Medical Center
Peoria, Illinois
University of Kentucky Lexington
Lexington, Kentucky
Ochsner Clinic Foundation
New Orleans, Louisiana
Minnesota Epilepsy Group, PA
Saint Paul, Minnesota
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Columbia University Medical Center
New York, New York
Neuroscience & Spine Institute
Charlotte, North Carolina
Oregon Health and Science University
Portland, Oregon
Thomas Jefferson University
Philadelphia, Pennsylvania
Medical University of South Carolina
Charleston, South Carolina
University of Texas
Houston, Texas
Covenant Medical Group
Lubbock, Texas
University of Texas Health Science Center
San Antonio, Texas
Aurora BayCare Medical Center
Green Bay, Wisconsin
Aurora St. Luke's Medical Center
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.